World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with technetium-99m to detect cancerous lesions in men…

Continue ReadingWorld first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men

Long-term Transcendental Meditation shown to improve stress and aging markers

A collaborative study conducted by researchers at Maharishi International University (MIU), the University of Siegen, and the Uniformed Services University of the Health Sciences reveals that individuals practicing Transcendental Meditation…

Continue ReadingLong-term Transcendental Meditation shown to improve stress and aging markers